Insights - Page 53 of 107 - LucidQuest Ventures

Oncology Today — October 20, 2025

October 20, 2025novartis,pfizer,BioPharma and Tech News,Ovarian Cancer,bladder cancer,ESMO 2025,Oncology News,Bicara Therapeutics,CorceptWhitehawk Therapeutics,HER2-positive breast cancer

Catch the latest Oncology news, featuring ESMO 2025 updates, FDA and EMA…

by LucidQuest

AI in Healthcare and Digital Health Today — October 20, 2025

October 20, 2025ckd,PDAC,BioPharma and Tech News,MASH,AI in Healthcare and Digital Health,WelldocLantern Pharma,Aptar Digital Health

From smarter diagnostics to data-driven decision-making, this weekly roundup…

by Timos Papagatsias

Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B

October 20, 2025regenerative medicine,clinical trials,FDA,dermatology,biopharma,Lucid Diligence Brief,payer access,venture financing,competitive landscape,hair lossandrogenetic alopecia

Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B Professional…

by Timos Papagatsias

Lucid Diligence Brief: Kardigan $254m Series B

October 19, 2025clinical trials,Regulatory,cardiovascular,biopharma,hypertension,antisense,Lucid Diligence Brief,payer access,diligence,venture financing,aortic stenosis,cardiomyopathysGC

Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…

by Timos Papagatsias

Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia

October 18, 2025digital health,clinical trials,market access,reimbursement,Regulatory,biopharma,Lucid Diligence Brief,payer access,diligence,oncology diagnosticsAsia healthcare

Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia…

by Timos Papagatsias

Public Health Today - October 17, 2025

October 17, 2025antibiotic resistance,Depression,BioPharma and Tech News,obesity,als,Ozempic,Pfizer BioNTech,Public Health News,GLP-1s,mRNA COVID vaccinesgut virome,neurological epidemiology

This week's public health update highlights major developments in disease…

by LucidQuest

Vaccines Video Recap – October 17, 2025

October 17, 2025BioPharma and Tech News,mpoxmelanoma,shingles vaccine,Alzheimer's Vaccine,Alzinova,GC Biopharma,Vaccine news,Everest Medicines,Clover Biopharma,Moderna’s mRNA-4359

In this biweekly video summary, we spotlight recent progress across the…

by LucidQuest

Vaccines Today - October 17, 2025

October 17, 2025cancer vaccines,BioPharma and Tech News,melanoma,SK Bioscience,GC Biopharma,Vaccine news,Everest MedicinesClover Biopharma,Moderna mRNA-4359

This week Vaccines update features the latest updates, industry progress, and…

by LucidQuest

Respiratory Video Recap—October 17, 2025

October 17, 2025IPF,merck,COPD,Asthma,BioPharma and Tech News,Boehringer Ingelheim,Savara,InvivydRespiratory News,Chiesi

Stay informed with this biweekly overview of the latest in respiratory. We…

by LucidQuest

Lucid Diligence Brief: EVOQ x Sanofi collaboration

October 17, 2025clinical trials,Regulatory,sanofi,immunology,biopharma,autoimmune,Lucid Diligence Brief,payer access,antigen-specific tolerance,licensing dealsEVOQ

Lucid Diligence Brief: EVOQ x Sanofi collaboration Professional audiences only.…

by Timos Papagatsias

Respiratory Today—October 17, 2025

October 17, 2025IPF,COPD,Asthma,BioPharma and Tech News,Boehringer Ingelheim,Respiratory News,Sunshine Biopharma,SARS-CoV-2,Rein Therapeutics,Changxi Pharmaceutical,Oticara4D Molecular Therapeutics,Tvardi

Explore this week’s Respiratory highlights, including new developments,…

by LucidQuest

Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration

October 16, 2025biologics,drug discovery,AI in healthcare,biopharma,BD,Lucid Diligence Brief,diligence,protein design,partnershipsADCs

Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design…

by Timos Papagatsias

Minimize Uncertainty – Make Informed Decisions – Succeed